![]() | ![]() |
Formats:
|
||||||||||||||||||||||
Copyright © 2007, American Society for Microbiology Phosphorylation of Slx4 by Mec1 and Tel1 Regulates the Single-Strand Annealing Mode of DNA Repair in Budding Yeast MRC Protein Phosphorylation Unit, James Black Centre, University of Dundee, Dundee DD1 5EH, United Kingdom,1 Institute of Human Genetics, CNRS UPR 1142, 141 Rue de la Cardonille, 34396 Montpellier, France,2 Rosenstiel Basic Medical Sciences Research Centre, Waltham, Massachusetts3 *Corresponding author. Mailing address: MRC Protein Phosphorylation Unit, James Black Centre, University of Dundee, Dundee DD1 5EH, United Kingdom. Phone: 44-1382-385490. Fax: 44-1382-223778. E-mail: j.rouse/at/dundee.ac.uk †Present address: Gurdon/CRUK Institute, University of Cambridge, Tennis Court Rd., Cambridge, United Kingdom. Received January 22, 2007; Revised June 1, 2007; Accepted June 28, 2007. This article has been cited by other articles in PMC.Abstract Budding yeast (Saccharomyces cerevisiae) Slx4 is essential for cell viability in the absence of the Sgs1 helicase and for recovery from DNA damage. Here we report that cells lacking Slx4 have difficulties in completing DNA synthesis during recovery from replisome stalling induced by the DNA alkylating agent methyl methanesulfonate (MMS). Although DNA synthesis restarts during recovery, cells are left with unreplicated gaps in the genome despite an increase in translesion synthesis. In this light, epistasis experiments show that SLX4 interacts with genes involved in error-free bypass of DNA lesions. Slx4 associates physically, in a mutually exclusive manner, with two structure-specific endonucleases, Rad1 and Slx1, but neither of these enzymes is required for Slx4 to promote resistance to MMS. However, Rad1-dependent DNA repair by single-strand annealing (SSA) requires Slx4. Strikingly, phosphorylation of Slx4 by the Mec1 and Tel1 kinases appears to be essential for SSA but not for cell viability in the absence of Sgs1 or for cellular resistance to MMS. These results indicate that Slx4 has multiple functions in responding to DNA damage and that a subset of these are regulated by Mec1/Tel1-dependent phosphorylation. The RecQ helicases are important regulators of genome stability. Human cells have several RecQ family helicases, including BLM and WRN, that are mutated in Werner's and Bloom's syndromes, respectively (19, 25). Yeasts have a single RecQ helicase: Sgs1 in Saccharomyces cerevisiae and Rqh1 in Schizosaccharomyces pombe. Cells lacking Sgs1 or Rqh1 exhibit high rates of chromosome loss and rearrangements, an elevated incidence of loss of heterozygosity, increased rates of sister chromatid exchange, hypersensitivity to agents that damage DNA, and defects in meiosis (15, 25, 30, 48, 50). Sgs1 is also important for preventing recombination between divergent sequences in the single-strand annealing (SSA) mode of double-strand break (DSB) repair (32, 42, 43). Sgs1 interacts with DNA topoisomerase III (Top3), and together Sgs1 and Top3 can dissolve double Holliday junctions (dHJs) in vitro (49). It is thought that this activity promotes the resolution of recombination intermediates during restart of stalled or blocked replisomes (25). Replisomes blocked by DNA damage can bypass lesions by at least two different mechanisms: translesion synthesis (TLS) across the damaged base by TLS polymerases and error-free bypass, also known as “template switching” (34, 47). Template switching is thought to involve unpairing of the nascent strands from the parental template and their subsequent annealing (20, 39). The nascent strand that had been blocked is then elongated using the nascent sister strand as template. The resulting structures may be converted to pseudo-dHJs, in a Rad51/Rad52-dependent manner, and cells lacking Sgs1 accumulate these pseudo-dHJs presumably because it normally helps to dissolve them (27). There is experimental evidence to support template switching at blocked replisomes in yeast (53), but the mechanisms involved are unclear, as are many of the relevant genes. Despite these important roles, Sgs1 is not essential for cell viability. However, a screen for genes required for viability in the absence of SGS1 (or TOP3) identified six “SLX” genes. The products of these genes form three heterodimeric complexes in cells: Slx2 (Mms4)/Slx3 (Mus81), Slx5/Slx8, and Slx1/Slx4 (31). The precise cellular roles of Slx5 and Slx8 are unclear, although cells lacking either protein showed an increased rate of gross chromosomal rearrangements (52). Mms4-Mus81 is a structure-specific endonuclease that, at least in vitro, preferentially cleaves branched DNA structures resembling structures that arise during recombinational processing of stalled replication forks (2, 23). The synthetic lethality of sgs1 mus81 cells is suppressed when RAD52 is deleted (2, 10), suggesting Mus81 cleaves dHJs when they are not dissolved by Sgs1 during recombinational processing of stalled replisomes. Slx1-Slx4 from budding yeast and fission yeast is also a structure-specific endonuclease with preference in vitro for branched DNA substrates, especially simple-Y, 5′-flap, or replication fork-like structures (7, 14). Slx1-Slx4 is likely to define a pathway distinct from Mms4-Mus81, because the synthetic lethality of sgs1Δ slx1Δ or sgs1Δ slx4Δ cells cannot be rescued by deletion of RAD52 (2, 10). Slx4 has no obvious catalytic or structural motifs, apart from a cryptic SAP domain, but Slx1 has a PHD-type zinc finger and is the founding member of a conserved family of nucleases defined by a UvrC-intron-endonuclease (URI) domain (14). While some of the cellular functions of Slx1 and Slx4 proteins are likely to overlap, given that these proteins interact and are both required for viability in the absence of Sgs1, cells lacking Slx4 are hypersensitive to DNA alkylation damage whereas cells lacking Slx1 are not (5, 31). Furthermore, phosphorylation of Esc4/Rtt107 is defective in cells lacking Slx4 but not in cells lacking Slx1 (36). Moreover, Slx4 is required for recovery from methyl methanesulfonate (MMS)-induced replisome stalling but Slx1 is not (36). Therefore, at least a subset of the cellular roles of Slx1 and Slx4 appears to be distinct. Slx4 has been also shown to interact physically with proteins other than Slx1. A genome-wide two-hybrid screen identified the Rad1 endonuclease as an Slx4 interactor (22). Rad1 catalyzes DNA incision on the 5′ side of UV-induced lesions and cleaves nonhomologous tails generated by DNA end resection during the SSA mode of DNA repair, responsible for repair of double-strand breaks between repeated sequences (1, 11). However, it is not clear if the endogenous cellular form of Slx4 interacts with Rad1 or if this impacts on the function of either protein. Several groups reported that Slx4 interacts with Esc4/Rtt107 (6, 36, 51). Esc4 was originally identified in a screen for genes that regulate retrotransposition in yeast (40) and in global genome screens for genes required for resistance to MMS (5, 17). Esc4 was subsequently shown to be required for completion of chromosome replication after replisome stalling (36, 37), but it is not yet known how it fulfills this task. Cells lacking Esc4 are hypersensitive to a wide range of agents that cause replisome stalling: camptothecin (CPT; causes S-phase-specific DSBs and replisome collapse) and hydroxyurea (HU; slows replication down by depleting deoxynucleoside triphosphates), as well as MMS, whereas cells lacking Slx4 are not hypersensitive to CPT or HU, suggesting that Esc4 has cellular roles not shared by Slx4. However, esc4Δ and slx4Δ cells show a comparable level of hypersensitivity to MMS and are epistatic in this regard, suggesting that they share a similar role in promoting resistance to MMS. Slx4 becomes phosphorylated in response to a wide range of different types of DNA damage, at all cell cycle stages, and this requires both the Mec1 and Tel1 protein kinases (12). These kinases, the yeast orthologues of ATR and ATM in higher eukaryotes, respectively, belong to the PIKK family of kinases, which also includes DNA-dependent protein kinase (DNA-PK) (45). Mec1 and Tel1 phosphorylate target proteins, including the Chk1 and Rad53 kinases, on Ser/Thr-Gln (S/T-Q) motifs and are critically important regulators of several aspects of the cellular response to DNA damage and stalled replisomes (45). The Slx4 residues phosphorylated by Mec1 and Tel1 and the functional significance of Slx4 phosphorylation are not yet known. Here we report that Slx4 has at least three independent cellular functions that appear to require different Slx4-interacting proteins, and we show that one of these functions is regulated by Slx4 phosphorylation. MATERIALS AND METHODS Yeast strains, plasmids, and antibodies. All strains used in this study are listed in Table 1. Disruption of SLX4 was carried out by transforming the relevant strains with the KAN-MX-disrupted SLX4 gene amplified from strain SFY008. Gene disruption was tested where possible by screening for MMS hypersensitivity and then verified by PCR. PEP4 disruption was achieved by transforming cells with a PCR product corresponding to the LEU2-disrupted PEP4, amplified from genomic DNA of strain GA1701 (9). PEP4 disruption was found to curtail Slx4 degradation in native cell extracts. Strain SFY013 was constructed by replacing the KANMX cassette in strain SFY008 with a NAT resistance gene. To make plasmid pSLX4, the SLX4 open reading frame plus 1 kb of 5′ sequence was cloned into pRS413, and the SLX4 start ATG was mutated to an NcoI site. After digestion with NcoI, 13 copies of a MYC epitope tag were ligated into the NcoI site. All mutations in SLX4 were introduced using the QuikChange site-directed mutagenesis kit (Stratagene). Mouse monoclonal antibodies against Myc (clone 9E10) and hemagglutinin (HA) were from Roche, and antibodies against Rad1 were from Santa Cruz Biotechnology. Antibodies against Rad10 were a kind gift from Errol Friedberg.
Analysis of chromosomes by PFGE. Cells were grown to early log phase (optical density [OD600], 0.5) in yeast extract-peptone-dextrose (YPD) at 30°C and arrested in G1 by addition of α-factor (5 μg/ml). When budded cells accounted for less than 5% of the population, cells were released from arrest by filtration and extensive washing and incubated in YPD for 10 min before addition of MMS (0.05%). After 45 min in MMS, cells were filtered, washed extensively with YPD containing 2.5% (wt/vol) sodium thiosulfate, and incubated in YPD at 30°C. At the times indicated, 1 × 108 cells were removed and fixed in 70% ethanol at 4°C overnight before preparation of chromosomes, exactly as described in the CHEF DRII instruction manual (Bio-Rad). Pulsed-field gel electrophoresis (PFGE) was carried out using a Bio-Rad CHEF DRII apparatus at 14°C in a 1% agarose gel (pulsed-field certified; Bio-Rad) in 0.5× Tris-borate-EDTA for 24 h at 6 V/cm using a 120o included angle with a 6.8- to 158-s switch-time ramp. Gels were stained with 10 μg/ml ethidium bromide for 30 min and washed for 2 min in water before DNA was visualized. Measurement of spontaneous mutation frequency. The frequency of forward mutations at the CAN1 gene locus was determined by the frequency of appearance of canavanine-resistant colonies that grew on selective minimal medium plates lacking Arg but containing canavanine (60 μg/ml) (for example, see reference 42a). Cultures were grown to stationary phase for 24 h in minimal medium lacking Arg. The OD600 of cultures was measured, and from the same culture, in parallel, approximately 2 × 107 cells were plated onto canavanine plates and 2 × 102 cells were plated onto YPD plates. The colonies were counted after incubation at 30°C for 3 days. To calculate spontaneous mutation frequencies, the number of canavanine-resistant colonies per ml of culture was divided by the number of CFU (on YPD) per ml of culture. Mutation frequencies represented the average from three independent triplicate experiments, and the relative frequency was calculated from the increase or decrease in mutation frequency in comparison to the wild-type strain. DNA combing. Wild-type and slx4Δ cells containing the human nucleotide transporter hENT1 on a centromeric plasmid (pRS415) and seven copies of the herpes simplex thymidine kinase gene were synchronized in late G1 for 2.5 h with 2 μg/ml α-factor (GenePep). Cells were released in S phase with 50 mg/ml Pronase (Calbiochem) in the presence of 30 μg/ml bromodeoxyuridine (BrdU) and 0.05% MMS. After 60 min, MMS was quenched with sodium thiosulfate and cells were resuspended in fresh medium containing 30 μg/ml BrdU. Genomic DNA was extracted in LMP agarose plugs (800 ng/plug) and was stained with YOYO-1 (Molecular Probes). DNA was resuspended in 50 mM morpholineethanesulfonic acid, pH 5.7, to a final concentration of 150 ng/ml. DNA fibers were stretched on silanized coverslips as described elsewhere (29) and were denatured for 25 min in 1 N NaOH. BrdU was detected with a rat monoclonal antibody (clone BU1/75; AbCys) and a secondary antibody coupled to Alexa 488 (Molecular Probes). DNA molecules were counterstained with an antiguanosine antibody (Argene) and an anti-mouse IgG coupled to Alexa 546 (Molecular Probes). Images were recorded with a Leica DM6000B microscope coupled to a CoolSNAP HQ charge-coupled device camera (Roper Scientific) and were processed as described previously (33). MetaMorph v6.2 (Universal Imaging Corp.) was used to measure BrdU signals and DNA fibers, and statistical analysis was performed with Prism 4 (GraphPad Software, Inc.). Antibody production. All peptides were synthesized by Graham Bloomberg, University of Bristol. Antibodies against phosphorylation sites in Slx4 were raised at the Scottish Antibody Production Unit (Lanarkshire, Scotland) by immunizing sheep with the following peptides coupled to keyhole limpet hemocyanin: AQKSPMpTQETTKN (phospho-Thr-72), LDNQESpSQQRLWT (phospho-Ser-289), and VNFLSLpSQVMDDK (phospho-Ser-329), where pS and pT are phospho-Ser and phospho-Thr, respectively. Antibodies were purified by affinity chromatography on CH-Sepharose to which the phosphopeptide immunogen had been covalently coupled. Phospho-specific antibodies were used at a final concentration of 4 μg/ml in the presence of 50 μg/ml non-phospho peptide in a Western blot analysis. Miscellaneous methods. Western blotting of extracts prepared by the trichloroacetic acid lysis method (38), preparation of native cell extracts and Myc-Slx4 immunoprecipitation, measurement of SSA induced by a run of trinucleotide repeats placed between direct repeats (13), measurement of HO-induced SSA (16) and fluorescence-activated cell sorter (FACS) analysis (12) were all carried out as described previously. RESULTS Analysis of DNA replication during recovery from MMS-induced replisome stalling in cells lacking Slx4. The major DNA lesion induced by MMS, N3-methyl adenine, potently blocks replisome progression (3). Roberts et al. showed that Slx4 is required for recovery of DNA replication after MMS-induced replisome stalling (36). We obtained similar data (Fig. (Fig.1A).1A
We wished to test if this lack of recovery from MMS-induced replisome stalling in the absence of Slx4 reflected an inability to resume DNA synthesis or whether instead cells could resume DNA replication but could not complete it. Cells were released from α-factor arrest into S phase in the presence of MMS and then washed free of MMS. FACS analysis (Fig. (Fig.1B)1B SLX4 interacts with genes involved in error-free DNA damage bypass genes. One possible explanation for the recovery defect described above could be that Slx4 promotes repair of DNA alkylation damage. Epistasis analysis with mutants defective in base excision repair (BER), the principal pathway for repair of DNA alkylation damage, was carried out. Cells lacking both SLX4 and methyladenine DNA glycosylase (MAG1), a BER factor that cleaves methylated bases to leave an abasic site in DNA, are more sensitive to MMS than either of the respective single mutants (Fig. (Fig.2A).2A
Alternatively, Slx4 could promote recovery from replisome stalling by regulating bypass of fork-blocking lesions. Bypass requires Rad6/Rad18-dependent ubiquitination of Lys164 of proliferating cell nuclear antigen (PCNA) (34, 47). Consequently, cells in which Lys164 of PCNA (Pol30 in budding yeast) is mutated to Arg are hypersensitive to MMS (21). When SLX4 was disrupted in pol30 lys164arg mutant cells, the double mutants were not more sensitive to MMS than the most sensitive single mutant (Fig. (Fig.2B,2B There are two major pathways in cells for bypassing DNA lesions: TLS and error-free bypass (47). TLS occurs by transient recruitment to stalled replisomes of specialized TLS DNA polymerases that, unlike the replicative polymerases δ and , can replicate across DNA lesions (47). Rad6/Rad18-dependent mono-ubiquitination of PCNA at Lys164 is thought to recruit TLS polymerases to stalled replisomes. Error-free bypass requires the addition of further ubiquitin moieties to mono-Ub PCNA, and this is catalyzed by the Rad5/Mms2/Ubc13 complex (47). We sought to determine which of these bypass pathways is regulated by SLX4. The major error-prone translesion polymerase in budding yeast is polymerase ζ (Pol ζ), comprising Rev3, the catalytic subunit, and Rev7 (35, 47). The MMS sensitivity of slx4Δ rev3Δ cells was greater than that of the single mutants (Fig. (Fig.2C),2CTranslesion synthesis by Pol ζ is responsible for 50 to 75% of spontaneous cell mutations, and so deletion of Rev3 decreases cell mutation frequencies (26). In contrast, mutations in error-free bypass factors increase spontaneous mutation frequency because of compensatory increases in TLS (4, 41). We reasoned that if Slx4 regulates error-free bypass, then Slx4 deficiency should increase the frequency of spontaneous mutation. Therefore, the frequency of forward mutation in the CAN1 gene, which gives rise to canavanine resistance, was measured. In the genetic background used in this study, deletion of REV3 decreased spontaneous mutation frequency, whereas disruption of UBC13 caused an approximately 8.5-fold increase in mutation frequency (Table 2), consistent with previous reports (4). Cells lacking Slx4 showed an approximately fivefold increase in the frequency of mutation, and this was abrogated by deletion of Rev3 (Table 2). Therefore, cells lacking Slx4 have a “mutator” phenotype that is caused by increased translesion synthesis, like cells lacking error-free bypass factors. This is consistent with, but does not prove, a role for Slx4 in error-free DNA damage avoidance.
Slx4 interacts with Slx1 and with Rad1-Rad10 in a mutually exclusive manner. Slx4 does not have any catalytic motifs that could provide clues as to how it may participate in DNA processing reactions at blocked replisomes. However, Slx4 interacts with the Slx1 structure-specific endonuclease that can cleave branched structures, such as flaps, in vitro (14, 31). Genome-wide two-hybrid analysis revealed the Rad1 subunit of the Rad1-Rad10 endonuclease as a putative Slx4-interactor (22). We tested if cellular Slx4 could interact with Rad1 and if Slx1 was found in the same complex. Endogenous Slx4 was tagged at the C terminus with 13 copies of the Myc epitope in cells in which Slx1 was tagged at the N terminus with 12 copies of the HA epitope. Disruption of Sgs1 did not cause lethality in this background and the cells were not more sensitive to MMS than wild-type cells, strongly suggesting that epitope tagging did not affect the function of Slx4 or Slx1 (data not shown). As shown in Fig. Fig.3B,3B
It is easy to envisage how the catalytic activity of Rad1 and Slx1 could be useful during error-free bypass. However, cells lacking Slx1 (Fig. (Fig.1A)1A Slx4 regulates single-strand annealing. The observation that Slx4 interacts physically with Rad1-Rad10 in cells prompted us to test the role of Slx4 in Rad1-Rad10-dependent processes. Rad1-Rad10 is involved in NER, but as slx4Δ cells are not hypersensitive to UV (data not shown), Slx4 does not appear to be involved in NER. Rad1-Rad10 also plays an important role during the SSA mode of DSB repair that can repair a DSB between repeated sequences (Fig. (Fig.3D).3D Zakian and colleagues reported a system for measuring SSA repair of DSBs induced by a hairpin placed between two direct repeats (Fig. (Fig.3C,3C We tested the effect of disruption of Slx4 in a different assay for SSA that did not rely on TNRs for formation of DSBs. Instead, the HO endonuclease was induced to create a single DSB between 205-bp repeated segments of the URA3 gene (Fig. (Fig.3D)3D Phosphorylation of Slx4 by Mec1 and Tel1 regulates SSA. DNA damage induces Mec1/Tel1-dependent phosphorylation of Slx4 that is independent of Rad53 and Chk1 (12). Mec1/Tel1, ATR/ATM, and DNA-PK all have identical specificity in vitro, and even though DNA-PK is not found in yeasts, it phosphorylates the same motifs in vitro in Slx4 as Mec1 and Tel1 (45). Since DNA-PK is readily available, we determined the residues in Slx4 phosphorylated by DNA-PK in vitro as a starting point to ultimately find the residues phosphorylated in vivo by Mec1/Tel1. Incubation of recombinant His6-Slx4 with DNA-PK resulted in phosphorylation of His6-Slx4 with a stoichiometry of approximately 6 moles of phosphate per mole of Slx4 (data not shown). The sites phosphorylated in Slx4 were identified by a combination of mass spectrometry and Edman degradation (data not shown). These analyses revealed that Slx4 is phosphorylated in vitro by DNA-PK on the following six residues: Thr72, Thr113, Ser289, Thr319, Ser329, and Ser355, and all of these conformed to the S/T-Q consensus sequence (Table 3).
To test whether Slx4 is phosphorylated on these residues in vivo, phospho-specific antibodies were raised. Phosphopeptides corresponding to Thr113, Ser355, and Thr319 failed to generate antibodies capable of recognizing the phosphopeptide immunogen (data not shown). In contrast, dot blot analysis showed that affinity-purified phospho-specific antibodies raised against Thr72, Ser289, and Ser329 recognized the correct phosphopeptide immunogen but not the corresponding non-phospho peptide (Fig. (Fig.4B).4B
To test the potential role of Mec1/Tel1-mediated phosphorylation in regulating Slx4, different combinations of point mutations were introduced into the SLX4 gene expressed under the control of its own promoter from a low-copy-number plasmid. Initially, the three residues in Slx4 that were shown to be phosphorylated by Mec1 and Tel1 in vivo—Thr72, Ser289, and Ser329 (Fig. (Fig.4C)—were4C We tested if the Slx4 phosphorylation site mutants could rescue the MMS hypersensitivity of slx4Δ cells. Cells expressing Slx4-Mut3 (data not shown) or Slx4-Mut6 (Fig. (Fig.5A)5A
Cells lacking both sgs1Δ and slx4Δ are inviable but can be kept alive by a low-copy-number [pSGS1-URA3-ADE] plasmid expressing SGS1. These cells are sensitive to killing by FOA, which is converted to toxic intermediates by Ura3, since cells cannot lose the SGS1 plasmid (30, 31). sgs1Δ slx4Δ ade2 ade3 [pSGS1-URA3-ADE] cells (strain NJY561) (5) were transformed with the following HIS3 plasmids: empty plasmid (pRS413), pSLX4, or pSLX4-MUT6. Cells were then restreaked to YPD plates with or without 5-FOA. Cells transformed with empty plasmid (pRS413) are FOA sensitive and red (since they cannot lose the ADE3 gene). Introduction of SLX4 on a low-copy-number plasmid allowed sgs1Δ slx4Δ [pSGS1-URA3-ADE] cells to grow on FOA (Fig. (Fig.5B)5B DISCUSSION In this study we showed that Slx4 has at least three apparently independent cellular functions: protecting cells when Sgs1 is not functional, promoting cellular resistance to MMS, and SSA. We also demonstrated that phosphorylation of Slx4 by Mec1 and Tel1 regulates SSA but is not required for viability in sgs1Δ cells and is not required for cellular resistance to MMS. The inability of slx4Δ cells to recover from MMS-induced replisome stalling (Fig. (Fig.1A)1A Error-free bypass is thought to involve template switching initiated by unpairing and annealing of the blocked nascent strand with the intact nascent sister strand, but the mechanisms and gene products involved are not clear. After replication past the blockage, the nascent strands would unpair again and reanneal with the parental strands (20, 39). There is experimental evidence to support template switching at blocked replisomes in yeast (53), but since the mechanisms involved are unclear, as are many of the relevant genes, it is difficult to speculate about the potential role of Slx4. Template switching should involve the action of helicases and nucleases, and it is possible that Slx4 recruits one or more catalytic activities to replisomes blocked by DNA lesions. In this light, it is interesting that Slx4 interacts with Slx1 that in vitro cleaves structures that resemble those that may arise during error-free bypass. However, Slx1 is not required for cellular resistance to MMS. Genome-wide analysis revealed the Rad1 subunit of the Rad1-Rad10 nuclease as a potential Slx4 interactor, and in this study we demonstrated that cellular Slx4 interacts with Rad1-Rad10 (Fig. (Fig.3A).3A Slx4 interacts with Esc4, which is also required for recovery from replisome stalling (36, 37), but unlike Slx4, disruption of Esc4 causes sickness but not lethality in sgs1Δ cells (51). Cells lacking Esc4 are hypersensitive to CPT and HU (44), whereas cells lacking Slx4 are not (data not shown), suggesting that Slx4 and Esc4 have distinct functions. However, esc4Δ and slx4Δ cells show a comparable level of hypersensitivity to MMS and are epistatic in this regard (6, 36). In addition, Slx4 is required for phosphorylation of Esc4 by Mec1 (36), indicating that the Slx4-Esc4 interaction is functionally important. It remains to be determined how the association with Esc4 impacts on Slx4 function in promoting resistance to MMS. It will be of particular importance to examine the ability of these proteins to associate with stalled replisomes and how this is regulated. Rad1-Rad10 is essential for SSA (1, 11, 13), and because we found that Slx4 interacts with this complex, we tested if Slx4 regulates SSA. Indeed, slx4Δ cells showed a severe reduction in Rad1-Rad10-dependent SSA in two different assays (Fig. (Fig.3).3 In this study we identified six residues in Slx4 phosphorylated by DNA-PK in vitro. Phospho-specific antibodies demonstrated clearly that at least three of these sites—Thr72, Ser289, and Ser329—become phosphorylated in vivo in response to DNA damage but not in cells lacking both Mec1 and Tel1 kinases. Mutation of these three sites in Slx4 phosphorylated in vivo after DNA damage does not affect cell viability in the presence of MMS or viability in cells lacking Sgs1 but does inhibit Rad1-dependent SSA. This suggests that the role of Slx4 in SSA is distinct from its role in promoting cell viability in the absence of Sgs1 and in promoting resistance to MMS (Fig. (Fig.66
The Slx4-Rad1-Rad10 and Slx4-Slx1-Esc4 complexes appear to be functionally distinct, and phosphorylation of Slx4 by Mec1 and Tel1 appears to be required for the function of one of these complexes: Slx4-Rad1-Rad10, which mediates SSA. It will be vitally important to investigate the molecular basis for modulation of Slx4 function by phosphorylation. It is unlikely that phosphorylation promotes the interaction of Slx4 with Rad1-Rad10, since Slx4 interacts with these proteins even in the absence of DNA damage (Fig. (Fig.3A)3A Based on the data in this study, we postulate the existence of at least two mutually exclusive, functionally distinct Slx4-containing complexes (Fig. (Fig.6A).6A Acknowledgments We thank Helle Ulrich, Michael Fasullo, Virginia Zakian, and EUROSCARF for yeast strains and Steve Brill for useful reagents and advice. We are grateful to Susan Lees-Miller for the kind gift of DNA-PK. We thank the Antibody Production Team and James Hastie and Hilary MacLauchlan in the Division of Signal Transduction Therapy, University of Dundee, for help with raising and purifying antibodies and the DNA sequencing group for technical assistance. We are grateful to Tony Carr, Anton Gartner, and members of the Rouse laboratory for useful discussions and to S. Gasser for technical advice. S.F. was funded by a predoctoral fellowship from the Medical Research Council (MRC) UK, and work in the Rouse lab is funded by the MRC, the Association for International Cancer Research, and an EMBO Young Investigator Award. Footnotes Published ahead of print on 16 July 2007.REFERENCES 1. Bardwell, L., A. J. Cooper, and E. C. Friedberg. 1992. Stable and specific association between the yeast recombination and DNA repair proteins RAD1 and RAD10 in vitro. Mol. Cell Biol. 12:3041-3049. [PubMed] 2. Bastin-Shanower, S. A., W. M. Fricke, J. R. Mullen, and S. J. Brill. 2003. The mechanism of Mus81-Mms4 cleavage site selection distinguishes it from the homologous endonuclease Rad1-Rad10. Mol. Cell. Biol. 23:3487-3496. [PubMed] 3. Beranek, D. T. 1990. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat. Res. 231:11-30. [PubMed] 4. Brusky, J., Y. Zhu, and W. Xiao. 2000. UBC13, a DNA-damage-inducible gene, is a member of the error-free postreplication repair pathway in Saccharomyces cerevisiae. Curr. Genet. 37:168-174. [PubMed] 5. Chang, M., M. Bellaoui, C. Boone, and G. W. Brown. 2002. A genome-wide screen for methyl methanesulfonate-sensitive mutants reveals genes required for S phase progression in the presence of DNA damage. Proc. Natl. Acad. Sci. USA 99:16934-16939. [PubMed] 6. Chin, J. K., V. I. Bashkirov, W. D. Heyer, and F. E. Romesberg. 2006. Esc4/Rtt107 and the control of recombination during replication. DNA Repair (Amsterdam) 5:618-628. 7. Coulon, S., P. H. Gaillard, C. Chahwan, W. H. McDonald, J. R. Yates III, and P. Russell. 2004. Slx1-Slx4 are subunits of a structure-specific endonuclease that maintains ribosomal DNA in fission yeast. Mol. Biol. Cell 15:71-80. [PubMed] 8. Desany, B. A., A. A. Alcasabas, J. B. Bachant, and S. J. Elledge. 1998. Recovery from DNA replicational stress is the essential function of the S-phase checkpoint pathway. Genes Dev. 12:2956-2970. [PubMed] 9. Duncker, B. P., K. Shimada, M. Tsai-Pflugfelder, P. Pasero, and S. M. Gasser. 2002. An N-terminal domain of Dbf4p mediates interaction with both origin recognition complex (ORC) and Rad53p and can deregulate late origin firing. Proc. Natl. Acad. Sci. USA 99:16087-16092. [PubMed] 10. Fabre, F., A. Chan, W. D. Heyer, and S. Gangloff. 2002. Alternate pathways involving Sgs1/Top3, Mus81/ Mms4, and Srs2 prevent formation of toxic recombination intermediates from single-stranded gaps created by DNA replication. Proc. Natl. Acad. Sci. USA 99:16887-16892. [PubMed] 11. Fishman-Lobell, J., and J. E. Haber. 1992. Removal of nonhomologous DNA ends in double-strand break recombination: the role of the yeast ultraviolet repair gene RAD1. Science 258:480-484. [PubMed] 12. Flott, S., and J. Rouse. 2005. Slx4 becomes phosphorylated after DNA damage in a Mec1/Tel1-dependent manner and is required for repair of DNA alkylation damage. Biochem. J. 391:325-333. [PubMed] 13. Freudenreich, C. H., S. M. Kantrow, and V. A. Zakian. 1998. Expansion and length-dependent fragility of CTG repeats in yeast. Science 279:853-856. [PubMed] 14. Fricke, W. M., and S. J. Brill. 2003. Slx1-Slx4 is a second structure-specific endonuclease functionally redundant with Sgs1-Top3. Genes Dev. 17:1768-1778. [PubMed] 15. Gangloff, S., J. P. McDonald, C. Bendixen, L. Arthur, and R. Rothstein. 1994. The yeast type I topoisomerase Top3 interacts with Sgs1, a DNA helicase homolog: a potential eukaryotic reverse gyrase. Mol. Cell. Biol. 14:8391-8398. [PubMed] 16. Goldfarb, T., and E. Alani. 2005. Distinct roles for the Saccharomyces cerevisiae mismatch repair proteins in heteroduplex rejection, mismatch repair and nonhomologous tail removal. Genetics 169:563-574. [PubMed] 17. Hanway, D., J. K. Chin, G. Xia, G. Oshiro, E. A. Winzeler, and F. E. Romesberg. 2002. Previously uncharacterized genes in the UV- and MMS-induced DNA damage response in yeast. Proc. Natl. Acad. Sci. USA 99:10605-10610. [PubMed] 18. Hennessy, K. M., A. Lee, E. Chen, and D. Botstein. 1991. A group of interacting yeast DNA replication genes. Genes Dev. 5:958-969. [PubMed] 19. Hickson, I. D. 2003. RecQ helicases: caretakers of the genome. Nat. Rev. Cancer 3:169-178. [PubMed] 20. Higgins, N. P., K. Kato, and B. Strauss. 1976. A model for replication repair in mammalian cells. J. Mol. Biol. 101:417-425. [PubMed] 21. Hoege, C., B. Pfander, G. L. Moldovan, G. Pyrowolakis, and S. Jentsch. 2002. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419:135-141. [PubMed] 22. Ito, T., T. Chiba, R. Ozawa, M. Yoshida, M. Hattori, and Y. Sakaki. 2001. A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc. Natl. Acad. Sci. USA 98:4569-4574. [PubMed] 23. Kaliraman, V., J. R. Mullen, W. M. Fricke, S. A. Bastin-Shanower, and S. J. Brill. 2001. Functional overlap between Sgs1-Top3 and the Mms4-Mus81 endonuclease. Genes Dev. 15:2730-2740. [PubMed] 24. Kaye, J. A., J. A. Melo, S. K. Cheung, M. B. Vaze, J. E. Haber, and D. P. Toczyski. 2004. DNA breaks promote genomic instability by impeding proper chromosome segregation. Curr. Biol. 14:2096-2106. [PubMed] 25. Khakhar, R. R., J. A. Cobb, L. Bjergbaek, I. D. Hickson, and S. M. Gasser. 2003. RecQ helicases: multiple roles in genome maintenance. Trends Cell Biol. 13:493-501. [PubMed] 26. Lawrence, C. W., and V. M. Maher. 2001. Mutagenesis in eukaryotes dependent on DNA polymerase zeta and Rev1p. Philos. Trans. R. Soc. London B 356:41-46. [PubMed] 27. Liberi, G., G. Maffioletti, C. Lucca, I. Chiolo, A. Baryshnikova, C. Cotta-Ramusino, M. Lopes, A. Pellicioli, J. E. Haber, and M. Foiani. 2005. Rad51-dependent DNA structures accumulate at damaged replication forks in sgs1 mutants defective in the yeast ortholog of BLM RecQ helicase. Genes Dev. 19:339-350. [PubMed] 28. Luke, B., G. Versini, M. Jaquenoud, I. W. Zaidi, T. Kurz, L. Pintard, P. Pasero, and M. Peter. 2006. The cullin Rtt101p promotes replication fork progression through damaged DNA and natural pause sites. Curr. Biol. 16:786-792. [PubMed] 29. Michalet, X., R. Ekong, F. Fougerousse, S. Rousseaux, C. Schurra, N. Hornigold, M. van Slegtenhorst, J. Wolfe, S. Povey, J. S. Beckmann, and A. Bensimon. 1997. Dynamic molecular combing: stretching the whole human genome for high-resolution studies. Science 277:1518-1523. [PubMed] 30. Mullen, J. R., V. Kaliraman, and S. J. Brill. 2000. Bipartite structure of the SGS1 DNA helicase in Saccharomyces cerevisiae. Genetics 154:1101-1114. [PubMed] 31. Mullen, J. R., V. Kaliraman, S. S. Ibrahim, and S. J. Brill. 2001. Requirement for three novel protein complexes in the absence of the Sgs1 DNA helicase in Saccharomyces cerevisiae. Genetics 157:103-118. [PubMed] 32. Myung, K., A. Datta, C. Chen, and R. D. Kolodner. 2001. SGS1, the Saccharomyces cerevisiae homologue of BLM and WRN, suppresses genome instability and homeologous recombination. Nat. Genet. 27:113-116. [PubMed] 32a. Papouli, E., S. Chen, A. A. Davies, D. Huttner, L. Krejei, P. Sung, and H. D. Ulrich. 2005. Crosstalk between SUMO and ubiquitin on PCNA is mediated by recruitment of the helicase Srs2p. Mol. Cell 19:123-133. [PubMed] 33. Pasero, P., A. Bensimon, and E. Schwob. 2002. Single-molecule analysis reveals clustering and epigenetic regulation of replication origins at the yeast rDNA locus. Genes Dev. 16:2479-2484. [PubMed] 34. Prakash, L. 1981. Characterization of postreplication repair in Saccharomyces cerevisiae and effects of rad6, rad18, rev3 and rad52 mutations. Mol. Gen. Genet. 184:471-478. [PubMed] 35. Prakash, S., R. E. Johnson, and L. Prakash. 2005. Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. Annu. Rev. Biochem. 74:317-353. [PubMed] 36. Roberts, T. M., M. S. Kobor, S. A. Bastin-Shanower, M. Ii, S. A. Horte, J. W. Gin, A. Emili, J. Rine, S. J. Brill, and G. W. Brown. 2006. Slx4 regulates DNA damage checkpoint-dependent phosphorylation of the BRCT domain protein Rtt107/Esc4. Mol. Biol. Cell 17:539-548. [PubMed] 37. Rouse, J. 2004. Esc4p, a new target of Mec1p (ATR), promotes resumption of DNA synthesis after DNA damage. EMBO J 23:1188-1197. [PubMed] 38. Rouse, J., and S. P. Jackson. 2000. LCD1: an essential gene involved in checkpoint control and regulation of the MEC1 signalling pathway in Saccharomyces cerevisiae. EMBO J. 19:5801-5812. [PubMed] 39. Rupp, W. D., C. E. Wilde III, D. L. Reno, and P. Howard-Flanders. 1971. Exchanges between DNA strands in ultraviolet-irradiated Escherichia coli. J. Mol. Biol. 61:25-44. [PubMed] 40. Scholes, D. T., M. Banerjee, B. Bowen, and M. J. Curcio. 2001. Multiple regulators of Ty1 transposition in Saccharomyces cerevisiae have conserved roles in genome maintenance. Genetics 159:1449-1465. [PubMed] 41. Schurer, K. A., C. Rudolph, H. D. Ulrich, and W. Kramer. 2004. Yeast MPH1 gene functions in an error-free DNA damage bypass pathway that requires genes from Homologous recombination, but not from postreplicative repair. Genetics 166:1673-1686. [PubMed] 42. Spell, R. M., and S. Jinks-Robertson. 2004. Examination of the roles of Sgs1 and Srs2 helicases in the enforcement of recombination fidelity in Saccharomyces cerevisiae. Genetics 168:1855-1865. [PubMed] 42a. Stelter, P., and H. D. Ulrich. 2003. Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation. Nature 425:188-191. [PubMed] 43. Sugawara, N., T. Goldfarb, B. Studamire, E. Alani, and J. E. Haber. 2004. Heteroduplex rejection during single-strand annealing requires Sgs1 helicase and mismatch repair proteins Msh2 and Msh6 but not Pms1. Proc. Natl. Acad. Sci. USA 101:9315-9320. [PubMed] 43a. Thomas, B. J., and R. Rothstein. 1989. The genetic control of direct-repeat recombination in Saccharomyces: the effect of rad52 and rad1 on mitotic recombination at GAL10, a transcriptionally regulated gene. Genetics 123:725-738. [PubMed] 44. Tong, A. H., M. Evangelista, A. B. Parsons, H. Xu, G. D. Bader, N. Page, M. Robinson, S. Raghibizadeh, C. W. Hogue, H. Bussey, B. Andrews, M. Tyers, and C. Boone. 2001. Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science 294:2364-2368. [PubMed] 44a. Tourriere, H., G. Versini, V. Cordon-Preciado, C. Alabert, and P. Pasero. 2005. Mre1 and Tof1 promote replication fork progression and recovery independently of Rad53. Mol. Cell. 19:699-706. [PubMed] 45. Traven, A., and J. Heierhorst. 2005. SQ/TQ cluster domains: concentrated ATM/ATR kinase phosphorylation site regions in DNA-damage-response proteins. Bioessays 27:397-407. [PubMed] 46. Ui, A., M. Seki, H. Ogiwara, R. Onodera, S. Fukushige, F. Onoda, and T. Enomoto. 2005. The ability of Sgs1 to interact with DNA topoisomerase III is essential for damage-induced recombination. DNA Repair (Amsterdam) 4:191-201. 47. Ulrich, H. D. 2005. The RAD6 pathway: control of DNA damage bypass and mutagenesis by ubiquitin and SUMO. ChemBiochem 6:1735-1743. [PubMed] 48. Watt, P. M., I. D. Hickson, R. H. Borts, and E. J. Louis. 1996. SGS1, a homologue of the Bloom's and Werner's syndrome genes, is required for maintenance of genome stability in Saccharomyces cerevisiae. Genetics 144:935-945. [PubMed] 49. Wu, L., and I. D. Hickson. 2003. The Bloom's syndrome helicase suppresses crossing over during homologous recombination. Nature 426:870-874. [PubMed] 50. Yamagata, K., J. Kato, A. Shimamoto, M. Goto, Y. Furuichi, and H. Ikeda. 1998. Bloom's and Werner's syndrome genes suppress hyperrecombination in yeast sgs1 mutant: implication for genomic instability in human diseases. Proc. Natl. Acad. Sci. USA 95:8733-8738. [PubMed] 51. Zappulla, D. C., A. S. Maharaj, J. J. Connelly, R. A. Jockusch, and R. Sternglanz. 2006. Rtt107/Esc4 binds silent chromatin and DNA repair proteins using different BRCT motifs. BMC Mol. Biol. 7:40. [PubMed] 52. Zhang, C., T. M. Roberts, J. Yang, R. Desai, and G. W. Brown. 2006. Suppression of genomic instability by SLX5 and SLX8 in Saccharomyces cerevisiae. DNA Repair (Amsterdam) 5:336-346. 53. Zhang, H., and C. W. Lawrence. 2005. The error-free component of the RAD6/RAD18 DNA damage tolerance pathway of budding yeast employs sister-strand recombination. Proc. Natl. Acad. Sci. USA 102:15954-15959. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||
Nat Rev Cancer. 2003 Mar; 3(3):169-78.
[Nat Rev Cancer. 2003]Trends Cell Biol. 2003 Sep; 13(9):493-501.
[Trends Cell Biol. 2003]Mol Cell Biol. 1994 Dec; 14(12):8391-8.
[Mol Cell Biol. 1994]Genetics. 2000 Mar; 154(3):1101-14.
[Genetics. 2000]Genetics. 1996 Nov; 144(3):935-45.
[Genetics. 1996]Mol Gen Genet. 1981; 184(3):471-8.
[Mol Gen Genet. 1981]Chembiochem. 2005 Oct; 6(10):1735-43.
[Chembiochem. 2005]J Mol Biol. 1976 Mar 5; 101(3):417-25.
[J Mol Biol. 1976]J Mol Biol. 1971 Oct 14; 61(1):25-44.
[J Mol Biol. 1971]Genes Dev. 2005 Feb 1; 19(3):339-50.
[Genes Dev. 2005]Genetics. 2001 Jan; 157(1):103-18.
[Genetics. 2001]Mol Cell Biol. 2003 May; 23(10):3487-96.
[Mol Cell Biol. 2003]Genes Dev. 2001 Oct 15; 15(20):2730-40.
[Genes Dev. 2001]Proc Natl Acad Sci U S A. 2002 Dec 24; 99(26):16887-92.
[Proc Natl Acad Sci U S A. 2002]Mol Biol Cell. 2004 Jan; 15(1):71-80.
[Mol Biol Cell. 2004]Genes Dev. 2003 Jul 15; 17(14):1768-78.
[Genes Dev. 2003]Mol Cell Biol. 2003 May; 23(10):3487-96.
[Mol Cell Biol. 2003]Proc Natl Acad Sci U S A. 2002 Dec 24; 99(26):16887-92.
[Proc Natl Acad Sci U S A. 2002]Proc Natl Acad Sci U S A. 2002 Dec 24; 99(26):16934-9.
[Proc Natl Acad Sci U S A. 2002]Genetics. 2001 Jan; 157(1):103-18.
[Genetics. 2001]Mol Biol Cell. 2006 Jan; 17(1):539-48.
[Mol Biol Cell. 2006]Proc Natl Acad Sci U S A. 2001 Apr 10; 98(8):4569-74.
[Proc Natl Acad Sci U S A. 2001]Mol Cell Biol. 1992 Jul; 12(7):3041-9.
[Mol Cell Biol. 1992]Science. 1992 Oct 16; 258(5081):480-4.
[Science. 1992]Mol Biol Cell. 2006 Jan; 17(1):539-48.
[Mol Biol Cell. 2006]BMC Mol Biol. 2006 Nov 9; 7():40.
[BMC Mol Biol. 2006]Biochem J. 2005 Oct 15; 391(Pt 2):325-33.
[Biochem J. 2005]Bioessays. 2005 Apr; 27(4):397-407.
[Bioessays. 2005]Proc Natl Acad Sci U S A. 2002 Dec 10; 99(25):16087-92.
[Proc Natl Acad Sci U S A. 2002]Nature. 2003 Sep 11; 425(6954):188-91.
[Nature. 2003]Science. 1997 Sep 5; 277(5331):1518-23.
[Science. 1997]Genes Dev. 2002 Oct 1; 16(19):2479-84.
[Genes Dev. 2002]EMBO J. 2000 Nov 1; 19(21):5801-12.
[EMBO J. 2000]Science. 1998 Feb 6; 279(5352):853-6.
[Science. 1998]Genetics. 2005 Feb; 169(2):563-74.
[Genetics. 2005]Biochem J. 2005 Oct 15; 391(Pt 2):325-33.
[Biochem J. 2005]Mutat Res. 1990 Jul; 231(1):11-30.
[Mutat Res. 1990]Mol Biol Cell. 2006 Jan; 17(1):539-48.
[Mol Biol Cell. 2006]Genes Dev. 1998 Sep 15; 12(18):2956-70.
[Genes Dev. 1998]Genes Dev. 1991 Jun; 5(6):958-69.
[Genes Dev. 1991]Curr Biol. 2006 Apr 18; 16(8):786-92.
[Curr Biol. 2006]Science. 1997 Sep 5; 277(5331):1518-23.
[Science. 1997]Bioessays. 2005 Apr; 27(4):397-407.
[Bioessays. 2005]Mol Gen Genet. 1981; 184(3):471-8.
[Mol Gen Genet. 1981]Chembiochem. 2005 Oct; 6(10):1735-43.
[Chembiochem. 2005]Nature. 2002 Sep 12; 419(6903):135-41.
[Nature. 2002]Chembiochem. 2005 Oct; 6(10):1735-43.
[Chembiochem. 2005]Annu Rev Biochem. 2005; 74():317-53.
[Annu Rev Biochem. 2005]Philos Trans R Soc Lond B Biol Sci. 2001 Jan 29; 356(1405):41-6.
[Philos Trans R Soc Lond B Biol Sci. 2001]Curr Genet. 2000 Mar; 37(3):168-74.
[Curr Genet. 2000]Genetics. 2004 Apr; 166(4):1673-86.
[Genetics. 2004]Genes Dev. 2003 Jul 15; 17(14):1768-78.
[Genes Dev. 2003]Genetics. 2001 Jan; 157(1):103-18.
[Genetics. 2001]Proc Natl Acad Sci U S A. 2001 Apr 10; 98(8):4569-74.
[Proc Natl Acad Sci U S A. 2001]Genetics. 1996 Nov; 144(3):935-45.
[Genetics. 1996]Mol Biol Cell. 2006 Jan; 17(1):539-48.
[Mol Biol Cell. 2006]Mol Cell Biol. 1992 Jul; 12(7):3041-9.
[Mol Cell Biol. 1992]Science. 1992 Oct 16; 258(5081):480-4.
[Science. 1992]Science. 1998 Feb 6; 279(5352):853-6.
[Science. 1998]Proc Natl Acad Sci U S A. 2004 Jun 22; 101(25):9315-20.
[Proc Natl Acad Sci U S A. 2004]Science. 1992 Oct 16; 258(5081):480-4.
[Science. 1992]Biochem J. 2005 Oct 15; 391(Pt 2):325-33.
[Biochem J. 2005]Bioessays. 2005 Apr; 27(4):397-407.
[Bioessays. 2005]Biochem J. 2005 Oct 15; 391(Pt 2):325-33.
[Biochem J. 2005]Genetics. 2000 Mar; 154(3):1101-14.
[Genetics. 2000]Genetics. 2001 Jan; 157(1):103-18.
[Genetics. 2001]Proc Natl Acad Sci U S A. 2002 Dec 24; 99(26):16934-9.
[Proc Natl Acad Sci U S A. 2002]Curr Biol. 2004 Dec 14; 14(23):2096-106.
[Curr Biol. 2004]Mol Biol Cell. 2006 Jan; 17(1):539-48.
[Mol Biol Cell. 2006]J Mol Biol. 1976 Mar 5; 101(3):417-25.
[J Mol Biol. 1976]J Mol Biol. 1971 Oct 14; 61(1):25-44.
[J Mol Biol. 1971]Proc Natl Acad Sci U S A. 2005 Nov 1; 102(44):15954-9.
[Proc Natl Acad Sci U S A. 2005]Mol Biol Cell. 2006 Jan; 17(1):539-48.
[Mol Biol Cell. 2006]EMBO J. 2004 Mar 10; 23(5):1188-97.
[EMBO J. 2004]BMC Mol Biol. 2006 Nov 9; 7():40.
[BMC Mol Biol. 2006]Science. 2001 Dec 14; 294(5550):2364-8.
[Science. 2001]Mol Cell Biol. 1992 Jul; 12(7):3041-9.
[Mol Cell Biol. 1992]Science. 1992 Oct 16; 258(5081):480-4.
[Science. 1992]Science. 1998 Feb 6; 279(5352):853-6.
[Science. 1998]Proc Natl Acad Sci U S A. 2001 Apr 10; 98(8):4569-74.
[Proc Natl Acad Sci U S A. 2001]Genetics. 2001 Jan; 157(1):103-18.
[Genetics. 2001]Genetics. 1996 Nov; 144(3):935-45.
[Genetics. 1996]Genetics. 2001 Jan; 157(1):103-18.
[Genetics. 2001]Mol Biol Cell. 2006 Jan; 17(1):539-48.
[Mol Biol Cell. 2006]Science. 1998 Feb 6; 279(5352):853-6.
[Science. 1998]Proc Natl Acad Sci U S A. 2004 Jun 22; 101(25):9315-20.
[Proc Natl Acad Sci U S A. 2004]Genetics. 2000 Mar; 154(3):1101-14.
[Genetics. 2000]Curr Genet. 2000 Mar; 37(3):168-74.
[Curr Genet. 2000]